136. Temporal Development of Depression Biomarkers From the iSPOT-D Study: State or Trait

      In the quest for improving treatment prediction in depression, several promising prognostic baseline biomarkers for escitalopram, venlafaxine and sertraline have been identified, including frontal alpha asymmetry (FAA) and paroxysmal activity. As confirmed in our recent meta-analysis, FAA is not different between patients with and without depression, and hence it is hypothesized that FAA has state-independent characteristics. Differences in medication response in patients with paroxysmal EEG activity suggest a possible anticonvulsant property of sertraline relative to other antidepressants.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect